Literature DB >> 6762414

Clinical pharmacokinetics of disopyramide.

A Karim, C Nissen, D L Azarnoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6762414     DOI： 10.1007/bf01059032

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  61 in total

1.  Rapid gas chromatographic determination of disopyramide in serum using a nitrogen detector.

Authors:  A M Duchateau; F W Merkus; F Schobben
Journal:  J Chromatogr       Date:  1975-06-18

2.  Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine.

Authors:  T C Hutsell; S J Stachelski
Journal:  J Chromatogr       Date:  1975-03-19

3.  Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.

Authors:  R E Rangno; W Warnica; R I Ogilvie; J Kreeft; E Bridger
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

4.  Placental and milk transfer of disopyramide and metabolites.

Authors:  A Karim; C Kook; J Campion
Journal:  Drug Metab Dispos       Date:  1978 May-Jun       Impact factor: 3.922

5.  Fluorescence photometric determination of disopyramide and mono-N-dealkylated disopyramide in plasma after separation by thin-layer chromatography.

Authors:  R N Gupta; F Eng; D Lewis; C Kumana
Journal:  Anal Chem       Date:  1979-03       Impact factor: 6.986

6.  Gas-chromatographic determination of disopyramide in serum, with use of a nitrogen-selective detector.

Authors:  J Vasiliades; C Owens; D Pirkle
Journal:  Clin Chem       Date:  1979-02       Impact factor: 8.327

7.  Assay of disopyramide in plasma by high-pressure liquid chromatography.

Authors:  K F Ilett; L P Hackett; L J Dusci; R Tjokrosetio
Journal:  J Chromatogr       Date:  1978-07-21

8.  Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.

Authors:  C S Cook; A Karim; P Sollman
Journal:  Drug Metab Dispos       Date:  1982 Mar-Apr       Impact factor: 3.922

9.  Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.

Authors:  A Johnston; J A Henry; S J Warrington; N A Hamer
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

10.  Effects of quinidine and disopyramide on serum digoxin concentrations.

Authors:  E G Manolas; D Hunt; G Sloman
Journal:  Aust N Z J Med       Date:  1980-08
View more
  9 in total

Review 1.  Therapeutic drug monitoring: antiarrhythmic drugs.

Authors:  T J Campbell; K M Williams
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

2.  Bioavailability of disopyramide in normal volunteers using unbound concentration.

Authors:  J Braun; F Sörgel; W P Gluth; S Oie
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; H Harashima; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

4.  Pharmacokinetic-pharmacodynamic analysis of unbound disopyramide directly measured in serial plasma samples in man.

Authors:  M Thibonnier; N H Holford; R A Upton; C D Blume; R L Williams
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

5.  A comparison of the anticholinergic effects of two formulations of disopyramide in healthy volunteers.

Authors:  J Longmore; J L Berry; E Szabadi; C M Bradshaw
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.

Authors:  J L Bauman; M D Schoen; T J Hoon
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

7.  Does alpha 1-acid glycoprotein reduce the unbound metabolic clearance of disopyramide in patients with renal impairment?

Authors:  J Braun; F Sörgel; W P Gluth; S Oie
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 8.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

9.  Atenolol inhibits the elimination of disopyramide.

Authors:  J Bonde; S Bødtker; H R Angelo; T L Svendsen; J P Kampmann
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.